Zapping AFib: new heart procedure trial seeks to control irregular heartbeat
NCT ID NCT07018596
Summary
This study is testing a new medical device called the CellFX system, which uses brief electrical pulses to treat a common type of irregular heartbeat called paroxysmal atrial fibrillation (AFib). The goal is to see if this procedure is safe and effective for people whose AFib symptoms come back despite taking medication. About 215 participants with this specific, drug-resistant AFib will have the ablation procedure, and researchers will track their health outcomes for six months afterward.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION (PAROXYSMAL) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Na Homolce Hospital
Prague, Roentgenova, 37/2, Czechia
Contact
Contact
Conditions
Explore the condition pages connected to this study.